UBS’s ProShares Ultra Health Care RXL Stock Holding History

UBS’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-3,416	Closed	-$39K	–	10749
2014 Q1	$39K	Buy	3,416 +144	+4%	+$1.59K	﹤0.01%	7181
2013 Q4	$33K	Buy	+3,272	New	+$30.9K	﹤0.01%	7520

Other funds holding RXL

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Advisors Preferred Rockville, Maryland $679M AUM 22.19% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $8.94B AUM 20.84% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS's RXL Position: Q2 2014 in Review

UBS sold out of ProShares Ultra Health Care (RXL) in Q2 2014, closing a stake of 3,416 shares — an estimated $39K sold.

UBS first reported a position in RXL in Q4 2013 and held it in 2 quarters. The position peaked at $39K in Q1 2014. 19 funds tracked by Wall St. Rank hold RXL as of Q2 2014.

UBS reported no remaining ProShares Ultra Health Care position as of Q2 2014 after selling out during the quarter.
UBS sold 3,416 ProShares Ultra Health Care shares in Q2 2014, an estimated $39K.
UBS first reported a position in ProShares Ultra Health Care in Q4 2013 and held it in 2 quarters.
UBS's ProShares Ultra Health Care position peaked at $39K in Q1 2014.
19 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q2 2014.

Based on UBS's 13F filing for Q2 2014, filed 14 Aug 2014.